Literature DB >> 22451793

Salvage Treatment of Local Recurrence in Esthesioneuroblastoma: A Meta-analysis.

Mitchell R Gore1, Adam M Zanation.   

Abstract

Esthesioneuroblastoma has a local recurrence rate of ∼30%, but no standard regimen for salvage of local recurrence has been established. We report data from 678 patients from series published since 1990, with a risk reduction analysis of salvage with surgery, radiation, or combined surgery and radiation therapy. We found a 28.5% rate of local recurrence after treatment, and a 42.6% rate of successful salvage with surgery, radiation, or combined treatment. The odds ratio for successful salvage, defined as disease-free survival for at least 1 year, was not significantly different for combined surgery and radiation versus surgery alone or radiation alone or for surgery alone versus radiation alone. The salvage odds ratio for combined surgery and radiation therapy versus radiation therapy alone, 3.5, approached, but did not reach statistical significance. This study reveals a reasonable rate of successful salvage of local esthesioneuroblastoma recurrence using surgery, radiation, or combined surgery and radiation.

Entities:  

Keywords:  Esthesioneuroblastoma; nasal cavity; olfactory neuroblastoma; salvage; sinus

Year:  2011        PMID: 22451793      PMCID: PMC3312410          DOI: 10.1055/s-0030-1254406

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  41 in total

1.  [Olfactory esthesioneuromas].

Authors:  J Martel; V Darrouzet; J Y Duclos; J P Bébéar; D Stoll
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2000

2.  Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.

Authors:  B V Eden; R F Debo; J M Larner; M D Kelly; P A Levine; F M Stewart; R W Cantrell; W C Constable
Journal:  Cancer       Date:  1994-05-15       Impact factor: 6.860

3.  Olfactory neuroblastoma. Management and prognosis.

Authors:  B J Bailey; S Barton
Journal:  Arch Otolaryngol       Date:  1975-01

4.  Olfactory neuroblastoma: clinicopathologic and immunohistochemical characterization of four representative cases.

Authors:  J L Schmidt; R J Zarbo; J L Clark
Journal:  Laryngoscope       Date:  1990-10       Impact factor: 3.325

5.  Esthesioneuroblastoma: reflections of a 21-year experience.

Authors:  P A Levine; R Gallagher; R W Cantrell
Journal:  Laryngoscope       Date:  1999-10       Impact factor: 3.325

6.  Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.

Authors:  R C Miyamoto; L L Gleich; P W Biddinger; J L Gluckman
Journal:  Laryngoscope       Date:  2000-08       Impact factor: 3.325

7.  Olfactory neuroblastoma: past, present, and future?

Authors:  Valerie J Lund; David Howard; William Wei; Margaret Spittle
Journal:  Laryngoscope       Date:  2003-03       Impact factor: 3.325

8.  Esthesioneuroblastoma: prognosis and management.

Authors:  A Morita; M J Ebersold; K D Olsen; R L Foote; J E Lewis; L M Quast
Journal:  Neurosurgery       Date:  1993-05       Impact factor: 4.654

Review 9.  Nasal and paranasal sinus carcinoma: how can we continue to make progress?

Authors:  Pavel Dulguerov; Abdelkarim S Allal
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2006-04       Impact factor: 2.064

10.  Combined modality therapy of esthesioneuroblastoma.

Authors:  J Nicolas McLean; Sunjay R Nunley; Carmen Klass; Charles Moore; Susan Müller; Peter A S Johnstone
Journal:  Otolaryngol Head Neck Surg       Date:  2007-06       Impact factor: 3.497

View more
  5 in total

1.  Radiosurgery is an Effective Treatment for Recurrent Esthesioneuroblastoma: A Multicenter Study.

Authors:  Jamie J Van Gompel; Michael J Link; Jason P Sheehan; Zhiyuan Xu; David Mathieu; Hideyuki Kano; L Dade Lunsford
Journal:  J Neurol Surg B Skull Base       Date:  2014-06-04

2.  Patterns of regional and distant metastasis in esthesioneuroblastoma.

Authors:  Victoria E Banuchi; Laura Dooley; Nancy Y Lee; David G Pfister; Sean McBride; Nadeem Riaz; Mark H Bilsky; Ian Ganly; Jatin P Shah; Dennis H Kraus; Luc G T Morris
Journal:  Laryngoscope       Date:  2016-02-10       Impact factor: 3.325

3.  Proton therapy for pediatric and adolescent esthesioneuroblastoma.

Authors:  John T Lucas; Matthew M Ladra; Shannon M MacDonald; Paul M Busse; Alison M Friedmann; David H Ebb; Karen J Marcus; Nancy J Tarbell; Torunn I Yock
Journal:  Pediatr Blood Cancer       Date:  2015-03-27       Impact factor: 3.838

4.  Correlating the treatment outcome with tumor staging, grading, and various treatment modalities in patients with esthesioneuroblastoma.

Authors:  Shuchita Singh; Lavleen Singh; Richa Ranjan; Manoj Kumar Singh; Alok Thakar; Suresh Chandra Sharma
Journal:  South Asian J Cancer       Date:  2019 Apr-Jun

5.  Delaying Postoperative Radiotherapy in Low-Grade Esthesioneuroblastoma: Is It Worth the Wait?

Authors:  Satoshi Kiyofuji; Vijay Agarwal; Joshua D Hughes; Robert L Foote; Jeffrey R Janus; Eric J Moore; Caterina Giannini; Michael J Link; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2020-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.